Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab
Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab
Recruiting · NCT06796114 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not applicable | 2026-07-23 | NCT06796114 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Centre Hospitalier Universitaire de Besancon | 73 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Paul Strauss | Strasbourg | France | 27 |
| CH de Chalon sur Saône | Chalon-sur-Saône | France | 1 |
| CH de Mulhouse | Mulhouse | France | 3 |
| CHU de Besançon | Besançon | France | 26 |
| CHU de Reims | Reims | France | 24 |
| CHU Grenoble | Grenoble | France | 48 |
| CHU Poitiers | Poitiers | France | 70 |
| Hôpital Beaujon - APHP | Paris | France | 1 |
| Hôpital Henri Mondor - APHP | Paris | France | 1 |
| Hôpital La Pitié Salpêtrière - APHP | Paris | France | 1 |